Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001437749-20-021142
Filing Date
2020-10-14
Accepted
2020-10-14 19:27:54
Documents
1
Period of Report
2020-09-23

Document Format Files

Seq Description Document Type Size
1 FORM 3 rdgdoc.html 3  
1 FORM 3 rdgdoc.xml 3 1376
  Complete submission text file 0001437749-20-021142.txt   3056
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Issuer) CIK: 0001053691 (see all company filings)

EIN.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1317 CARLTON AVENUE SUITE 200 CHARLOTTESVILLE VA 22902
Business Address
ELDER WILLIAM ROBERT (Reporting) CIK: 0001828068 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37942 | Film No.: 201240044